In addition to the noncanonical pathway-activated RelB/p52 signaling, activation of the RelB/p50 complexes by the canonical pathway is also a critical event promoting the immunosuppressive state and GBM progression [108]. The gene discussed is NFKB2; the disease is glioblastoma.